Search
kosmix
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
Drug Information
 Drug Search
 Drug Interactions
 Image Database
 Pill Identifier
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Alzheimer's May Be Diabetes-Like Illness


Related Encyclopedia
 border=
Acoustic Neurinoma
Addison's Disease
Alzheimer's Disease
Bell's Palsy
More...

Related Healthscout Videos
 border=
Resurfacing Hips
Saving Memories
Bubbles Predict Heart Attacks
Reversing Paralysis
More...

Related Animations
 border=
Alzheimer's Disease
Diabetes
Erectile Dysfunction
Heart Attack
More...

Related Drug Information
 border=
Actonel
Actos
Adderal XR
Amaryl
More...

Related News Articles
 border=
Checklist May Help Cut Sudden Death in Athletes
Antidepressants Don't Help Kleptomaniacs
Diabetes Epidemic Spreading Worldwide: Experts
For Heart Attack Victims, Skip the Mouth-to-Mouth
More...

Page:  << Prev | 1 | 2 | 3 | Next >>

Whether restoring insulin to the brain can slow or reverse the progression of Alzheimer's is something that de la Monte's team is looking at now in animals. "The results are under review," she said.

"We are looking at a brain form of diabetes," de la Monte said. "One can look forward to approaches that may work in the brain which we already have available, or that might be modified to treat patients with neurodegeneration," she said.

De la Monte is convinced that what doctors call Alzheimer's is really several different conditions under one umbrella. "We will have to develop ways to be certain who has what kind of neurodegeneration," she said.

Text Continues Below



About 50 percent of patients diagnosed with dementia have Alzheimer's, de la Monte noted. "The others have a mixed condition or something else wrong with them," she said.

"There are a number of conditions that people call Alzheimer's disease," de la Monte said. "People are developing ways of testing insulin resistance in the brain, which will be necessary to validate any therapy that comes out of this."

However, one expert doesn't think that her team has yet made a convincing case for the theory.

"The paper overreaches," said Gandy.

He noted that de la Monte's group injected the rats' brains with Streptozotocin, the compound they used to inhibit local insulin production. So, it's not clear whether the brain changes her group noted were related to a lack of insulin, or this insult to the brain. "Streptozotocin, which causes oxidative stress, would be predicted to cause such stress in many tissues, including the brain," Gandy said.

In addition, changes the researchers observed in the brains of the mice were only modest, with no clear structural pathology evident, he said.

Another expert believes insulin's role in Alzheimer's may only be part of the picture.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 3/24/2006

Related Websites
 border=
MyDiabetesCentral.com - Get detailed information on diabetes, its types, symptoms, diagnosis, and treatment.
OurAlzheimers.com - Alzheimer's disease information – Alzheimer's symptoms, Alzheimer's care, stages of Alzheimer's, treatment, medication, prevention, causes, diagnosis, and resources.





New Features

FDA to Revise Herpes Test Rules

SOURCES: Suzanne M. de la Monte, M.D., M.P.H, neuropathologist, Rhode Island Hospital, professor, pathology and clinical neuroscience, Brown Medical School, Providence; Sam Gandy, M.D., Ph.D., chairman, Medical and Scientific Advisory Council, Alzheimer's Association, and director, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia; Zoe Arvanitakis, M.D., assistant professor, neurological sciences, Rush University Medical Center, Chicago; March 2006 Journal of Alzheimer's Disease


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map